Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab

ClinicalTrials.gov ID: NCT00238238

Public ClinicalTrials.gov record NCT00238238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Trial of Rituximab Versus Lenalidomide (REVLIMID™, Cc-5013) (IND#73034) Versus Rituximab + Lenalidomide in Recurrent Follicular Non-Hodgkin Lymphoma (NHL) That is Not Rituximab-Refractory

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Lenalidomide may also stop the growth of non-Hodgkin's lymphoma by blocking blood flow to the cancer. Giving rituximab together with lenalidomide may kill more cancer cells. This randomized phase II trial is studying how well rituximab and/or lenalidomide work in treating patients with follicular non-Hodgkin's lymphoma that is not refractory to rituximab.

Study identification

NCT ID
NCT00238238
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
97 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2006 (Type not available)
Primary completion
Jun 2012 (Actual)
Completion
Aug 2015 (Actual)
Last update posted
Mar 15, 2017

2006 – 2015

United States locations

U.S. sites
79
U.S. states
17
U.S. cities
51
Facility City State ZIP Site status
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658 —
Kaiser Permanente Medical Office -Vandever Medical Office San Diego California 92120 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5001 —
Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale Florida 33308 —
Ella Milbank Foshay Cancer Center at Jupiter Medical Center Jupiter Florida 33458 —
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140 —
Illinois CancerCare - Bloomington Bloomington Illinois 61701 —
Graham Hospital Canton Illinois 61520 —
Illinois CancerCare - Canton Canton Illinois 61520 —
Illinois CancerCare - Carthage Carthage Illinois 62321 —
Memorial Hospital Carthage Illinois 62321 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Eureka Community Hospital Eureka Illinois 61530 —
Illinois CancerCare - Eureka Eureka Illinois 61530 —
Galesburg Clinic, PC Galesburg Illinois 61401 —
Galesburg Cottage Hospital Galesburg Illinois 61401 —
Illinois CancerCare - Galesburg Galesburg Illinois 61401 —
Illinois CancerCare - Havana Havana Illinois 62644 —
Mason District Hospital Havana Illinois 62644 —
Illinois CancerCare - Kewanee Clinic Kewanee Illinois 61443 —
Illinois CancerCare - Macomb Macomb Illinois 61455 —
McDonough District Hospital Macomb Illinois 61455 —
Illinois CancerCare - Monmouth Monmouth Illinois 61462 —
BroMenn Regional Medical Center Normal Illinois 61761 —
Community Cancer Center Normal Illinois 61761 —
Illinois CancerCare - Community Cancer Center Normal Illinois 61761 —
Community Hospital of Ottawa Ottawa Illinois 61350 —
Oncology Hematology Associates of Central Illinois, PC - Ottawa Ottawa Illinois 61350 —
Cancer Treatment Center at Pekin Hospital Pekin Illinois 61554 —
Illinois CancerCare - Pekin Pekin Illinois 61603 —
Proctor Hospital Peoria Illinois 61614 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61615 —
Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria Illinois 61615 —
Methodist Medical Center of Illinois Peoria Illinois 61636 —
Illinois CancerCare - Peru Peru Illinois 61354 —
Illinois Valley Community Hospital Peru Illinois 61354 —
Illinois CancerCare - Princeton Princeton Illinois 61356 —
Perry Memorial Hospital Princeton Illinois 61356 —
Illinois CancerCare - Spring Valley Spring Valley Illinois 61362 —
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46845 —
Menorah Medical Center Overland Park Kansas 66209 —
Saint Luke's Hospital - South Overland Park Kansas 66213 —
Veterans Affairs Medical Center - Minneapolis Minneapolis Minnesota 55417 —
Saint Luke's Cancer Institute at Saint Luke's Hospital Kansas City Missouri 64111 —
St. Joseph Medical Center Kansas City Missouri 64114 —
North Kansas City Hospital Kansas City Missouri 64116 —
Heartland Hematology Oncology Associates, Incorporated Kansas City Missouri 64118 —
CCOP - Kansas City Kansas City Missouri 64131 —
Research Medical Center Kansas City Missouri 64132 —
Saint Luke's East - Lee's Summit Lee's Summit Missouri 64086 —
Liberty Hospital Liberty Missouri 64068 —
Heartland Regional Medical Center Saint Joseph Missouri 64506 —
Saint Joseph Oncology, Incorporated Saint Joseph Missouri 64507 —
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110 —
Methodist Estabrook Cancer Center Omaha Nebraska 68114 —
University Medical Center of Southern Nevada Las Vegas Nevada 89102 —
CCOP - Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care Concord New Hampshire 03301 —
New Hampshire Oncology - Hematology, PA - Hooksett Hooksett New Hampshire 03106 —
Lakes Region General Hospital Laconia New Hampshire 03246 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York 13057 —
New York Weill Cornell Cancer Center at Cornell University New York New York 10021 —
Kinston Medical Specialists Kinston North Carolina 28501 —
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096 —
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus Ohio 43210-1240 —
Cancer Centers of the Carolinas - Easley Easley South Carolina 29640 —
Bon Secours St. Francis Health System Greenville South Carolina 29601 —
Cancer Centers of the Carolinas - Faris Road Greenville South Carolina 29605 —
Cancer Centers of the Carolinas - Grove Commons Greenville South Carolina 29605 —
Greenville Hospital Cancer Center Greenville South Carolina 29605 —
CCOP - Greenville Greenville South Carolina 29615 —
Self Regional Cancer Center at Self Regional Medical Center Greenwood South Carolina 29646 —
Cancer Centers of the Carolinas - Greer Medical Oncology Greer South Carolina 29650 —
Cancer Centers of the Carolinas - Seneca Seneca South Carolina 29672 —
Cancer Centers of the Carolinas - Spartanburg Spartanburg South Carolina 29307 —
Mountainview Medical Berlin Corners Vermont 05602 —
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401 —
Danville Regional Medical Center Danville Virginia 24541 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00238238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2017 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00238238 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →